ImmunoPrecise Antibodies unveils antibody-engineering platform Abthena - Proactive Investors USA & Canada
ImmunoPrecise Antibodies unveils antibody-engineering platform Abthena Proactive Investors USA & CanadaAbthena produces bispecific antibodies, which don't occur naturally but can better target infectious diseases.